pharmaceuticals-and-healthcare

EMEA (Europe, Middle East and Africa) Needle-Free Drug Delivery Systems Market Report 2017


Published On : May 2017

Category : Pharmaceutical

No. of Pages : 110 pages

  • $4000
  • $8000

Please click below to avail discount on this report

Table of Contents

EMEA (Europe, Middle East and Africa) Needle-Free Drug Delivery Systems Market Report 2017
1 Needle-Free Drug Delivery Systems Overview
1.1 Product Overview and Scope of Needle-Free Drug Delivery Systems
1.2 Classification of Needle-Free Drug Delivery Systems
1.2.1 EMEA Needle-Free Drug Delivery Systems Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Needle-Free Drug Delivery Systems Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Jet-based Needle-free Injectors
1.2.4 Spring-based Needle-free Injectors
1.2.5 Laser-based Needle-free Injectors
1.3 EMEA Needle-Free Drug Delivery Systems Market by Application/End Users
1.3.1 EMEA Needle-Free Drug Delivery Systems Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Insulin Needle-free Drug Delivery
1.3.3 Vaccine Needle-free Drug Delivery
1.3.4 Pediatric Needle-free Drug Delivery
1.3.5 Pain Needle-free Drug Delivery
1.3.6 Other Needle-free Drug Delivery
1.4 EMEA Needle-Free Drug Delivery Systems Market by Region
1.4.1 EMEA Needle-Free Drug Delivery Systems Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Needle-Free Drug Delivery Systems (2012-2022)
1.5.1 EMEA Needle-Free Drug Delivery Systems Sales and Growth Rate (2012-2022)
1.5.2 EMEA Needle-Free Drug Delivery Systems Revenue and Growth Rate (2012-2022)

2 EMEA Needle-Free Drug Delivery Systems Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Needle-Free Drug Delivery Systems Market Competition by Players/Manufacturers
2.1.1 EMEA Needle-Free Drug Delivery Systems Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Needle-Free Drug Delivery Systems Revenue and Share by Players (2012-2017)
2.1.3 EMEA Needle-Free Drug Delivery Systems Sale Price by Players (2012-2017)
2.2 EMEA Needle-Free Drug Delivery Systems (Volume and Value) by Type/Product Category
2.2.1 EMEA Needle-Free Drug Delivery Systems Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Needle-Free Drug Delivery Systems Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Needle-Free Drug Delivery Systems Sale Price by Type (2012-2017)
2.3 EMEA Needle-Free Drug Delivery Systems (Volume) by Application
2.4 EMEA Needle-Free Drug Delivery Systems (Volume and Value) by Region
2.4.1 EMEA Needle-Free Drug Delivery Systems Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Needle-Free Drug Delivery Systems Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Needle-Free Drug Delivery Systems Sales Price by Region (2012-2017)

3 Europe Needle-Free Drug Delivery Systems (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Needle-Free Drug Delivery Systems Sales and Value (2012-2017)
3.1.1 Europe Needle-Free Drug Delivery Systems Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Needle-Free Drug Delivery Systems Revenue and Growth Rate (2012-2017)
3.2 Europe Needle-Free Drug Delivery Systems Sales and Market Share by Type
3.3 Europe Needle-Free Drug Delivery Systems Sales and Market Share by Application
3.4 Europe Needle-Free Drug Delivery Systems Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Needle-Free Drug Delivery Systems Sales Volume by Countries (2012-2017)
3.4.2 Europe Needle-Free Drug Delivery Systems Revenue by Countries (2012-2017)
3.4.3 Germany Needle-Free Drug Delivery Systems Sales and Growth Rate (2012-2017)
3.4.4 France Needle-Free Drug Delivery Systems Sales and Growth Rate (2012-2017)
3.4.5 UK Needle-Free Drug Delivery Systems Sales and Growth Rate (2012-2017)
3.4.6 Russia Needle-Free Drug Delivery Systems Sales and Growth Rate (2012-2017)
3.4.7 Italy Needle-Free Drug Delivery Systems Sales and Growth Rate (2012-2017)
3.4.8 Benelux Needle-Free Drug Delivery Systems Sales and Growth Rate (2012-2017)

4 Middle East Needle-Free Drug Delivery Systems (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Needle-Free Drug Delivery Systems Sales and Value (2012-2017)
4.1.1 Middle East Needle-Free Drug Delivery Systems Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Needle-Free Drug Delivery Systems Revenue and Growth Rate (2012-2017)
4.2 Middle East Needle-Free Drug Delivery Systems Sales and Market Share by Type
4.3 Middle East Needle-Free Drug Delivery Systems Sales and Market Share by Application
4.4 Middle East Needle-Free Drug Delivery Systems Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Needle-Free Drug Delivery Systems Sales Volume by Countries (2012-2017)
4.4.2 Middle East Needle-Free Drug Delivery Systems Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Needle-Free Drug Delivery Systems Sales and Growth Rate (2012-2017)
4.4.4 Israel Needle-Free Drug Delivery Systems Sales and Growth Rate (2012-2017)
4.4.5 UAE Needle-Free Drug Delivery Systems Sales and Growth Rate (2012-2017)
4.4.6 Iran Needle-Free Drug Delivery Systems Sales and Growth Rate (2012-2017)

5 Africa Needle-Free Drug Delivery Systems (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Needle-Free Drug Delivery Systems Sales and Value (2012-2017)
5.1.1 Africa Needle-Free Drug Delivery Systems Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Needle-Free Drug Delivery Systems Revenue and Growth Rate (2012-2017)
5.2 Africa Needle-Free Drug Delivery Systems Sales and Market Share by Type
5.3 Africa Needle-Free Drug Delivery Systems Sales and Market Share by Application
5.4 Africa Needle-Free Drug Delivery Systems Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Needle-Free Drug Delivery Systems Sales Volume by Countries (2012-2017)
5.4.2 Africa Needle-Free Drug Delivery Systems Revenue by Countries (2012-2017)
5.4.3 South Africa Needle-Free Drug Delivery Systems Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Needle-Free Drug Delivery Systems Sales and Growth Rate (2012-2017)
5.4.5 Egypt Needle-Free Drug Delivery Systems Sales and Growth Rate (2012-2017)
5.4.6 Algeria Needle-Free Drug Delivery Systems Sales and Growth Rate (2012-2017)

6 EMEA Needle-Free Drug Delivery Systems Manufacturers/Players Profiles and Sales Data
6.1 3M Pharmaceuticals
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Needle-Free Drug Delivery Systems Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 3M Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Pharmajet
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Needle-Free Drug Delivery Systems Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Pharmajet Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Injex Pharma
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Needle-Free Drug Delivery Systems Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Injex Pharma Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Antares Pharma
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Needle-Free Drug Delivery Systems Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Antares Pharma Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Crossject
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Needle-Free Drug Delivery Systems Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Crossject Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Becton Dickinson (BD)
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Needle-Free Drug Delivery Systems Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Becton Dickinson (BD) Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 MedImmune
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Needle-Free Drug Delivery Systems Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 MedImmune Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Mystic Pharmaceuticals
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Needle-Free Drug Delivery Systems Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Optinose
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Needle-Free Drug Delivery Systems Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Optinose Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Valeritas
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Needle-Free Drug Delivery Systems Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Valeritas Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Zogenix

7 Needle-Free Drug Delivery Systems Manufacturing Cost Analysis
7.1 Needle-Free Drug Delivery Systems Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Needle-Free Drug Delivery Systems

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Needle-Free Drug Delivery Systems Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Needle-Free Drug Delivery Systems Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Needle-Free Drug Delivery Systems Market Forecast (2017-2022)
11.1 EMEA Needle-Free Drug Delivery Systems Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Needle-Free Drug Delivery Systems Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Needle-Free Drug Delivery Systems Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Needle-Free Drug Delivery Systems Price and Trend Forecast (2017-2022)
11.2 EMEA Needle-Free Drug Delivery Systems Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Needle-Free Drug Delivery Systems Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Needle-Free Drug Delivery Systems Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Needle-Free Drug Delivery Systems Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Needle-Free Drug Delivery Systems Sales Forecast by Type (2017-2022)
11.7 EMEA Needle-Free Drug Delivery Systems Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


Back To Top